[霍奇金病联合治疗后发生的低度非霍奇金淋巴瘤]
[Low grade non-Hodgkin's lymphoma after combined therapy for Hodgkin's disease].
作者信息
Raya Sánchez J M, González Brito G, Hernández Nieto L, Brito Barroso M L, Alvarez Argüelles H, Jorge Hernández J A, Martín Herrera A
机构信息
Servicio de Hematología y Hemoterapia, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife.
出版信息
Sangre (Barc). 1994 Dec;39(6):461-4.
The most serious complication of curative therapy for Hodgkin's disease is the development of a second malignancy. A patient who developed a low grade non-Hodgkin's lymphoma three years and a half after combined-modality therapy for Hodgkin's disease, is described. It is exceptional this type of non-Hodgkin's lymphoma as a second neoplasm after cytotoxic treatment for Hodgkin's disease. Pathogenic relationships between both processes are discussed.
霍奇金病根治性治疗最严重的并发症是发生第二种恶性肿瘤。本文描述了一名患者，其在接受霍奇金病综合治疗三年半后发生了低度非霍奇金淋巴瘤。这种类型的非霍奇金淋巴瘤作为霍奇金病细胞毒性治疗后的第二种肿瘤实属罕见。文中讨论了这两个过程之间的致病关系。
Zotero 插件